| Descript |
x, 219 p. : ill. ; 24 cm |
| Series |
Cancer drug discovery and development
|
| Note |
Papers from a conference held Apr. 2000 in Bryn Mawr, Pa |
|
Includes bibliographical references and index |
|
Antisense methodology / Fritz Eckstein -- Nucleic acid therapeutics / Alan M. Gewirtz -- Targeted genome modification via triple helix formation / Faye A. Rogers and Peter M. Glazer -- Therapeutic applications of ribozymes / John J. Rossi -- Use of catalytic DNA in target validation and therapeutics / Lun-Quan Sun -- Targeted destruction of small, stable RNAs / David A. Dunbar and Susan J. Baserga -- Mechanism of action of antisense RNA in eukaryotic cells / Zuo Zhang and Gordon G. Carmichael -- The transport of oligonucleotides into cells / R.L. Juliano -- Peptide-mediated delivery of antisense oligonucleotides and related material / Eric Vivås, Jean Philippe Richard and Bernard Lebleu -- Molecular vectors for gene delivery to cancer cells / Guy Zuber ... [et al.] -- Considerations on the design of antisense oligonucleotides / Rosel Kretschmer-Kazemi Far, Jens Warnecke and Georg Sczakiel -- Identification of hybridization accessible sequence in messenger RNA / Lida K. Gifford, Ponzy Lu, and Alan M. Gewirtz -- Nucleic acids as gene targeting therapeutics / Joanna B. Opalinska and Susan E. Shetzline -- LY900003 (Isis 3521) and G3139 (Genasense; Oblimersen) / C.A. Stein ... [et al.] -- Antisense protein kinase A-RI restores normal signal transduction signatures to inhibit tumor growth / Yoon S. Cho-Chung |
| Subject |
Antisense nucleic acids -- Therapeutic use
|
|
Cancer -- Chemotherapy
|
|
Neoplasms -- therapy -- Congresses
|
|
Gene Therapy -- methods -- Congresses
|
|
Nucleic Acids -- therapeutic use -- Congresses
|
| Alt Author |
Gewirtz, A. M. (Alan M.)
|
|
